Acquisitions30 Apr 2026, 11:11 pm
Rubicon completes 85% stake acquisition in Arinna Lifesciences
AI Summary
Rubicon Research Ltd has completed the secondary acquisition of an 85% stake in Arinna Lifesciences Limited on April 30, 2026. This follows an earlier intimation dated April 15, 2026, and was executed as per the terms of the Share Purchase Agreement. With the completion of this transaction, Arinna Lifesciences Limited is now a subsidiary of Rubicon Research Ltd.
Key Highlights
- Rubicon Research acquired an 85% stake in Arinna Lifesciences.
- The acquisition was completed on April 30, 2026.
- Arinna Lifesciences is now a subsidiary of Rubicon Research.
- This expands Rubicon Research's business operations.